Thus, by improving our understanding of the regulatory mechanisms that govern CCR2 expression on monocyte lineage cells, we can better appreciate how monocyte recruitment and activation is controlled during chronic inflammatory pathologies such as atherosclerosis. The gene discussed is CCR2; the disease is atherosclerosis.